Dr. Elliot Vesell, founding chair of the Department of Pharmacology at Penn State Health Milton S. Hershey Medical Center and assistant dean of graduate studies at Penn State College of Medicine, has passed away.
A new approach to killing C. difficile that silences key bacterial genes while sparing other bacteria may provide a new way to treat the most common hospital-acquired bacterial infection in the United States, according to researchers.
Five Penn State faculty members have been named Fellows of the American Association for the Advancement of Science.
A few recent attempts to treat melanoma have been either unsuccessful, or not successful enough. Penn State College of Medicine researchers have blended two approaches to create a compound that is showing initial success with killing melanoma cells and inhibiting tumor growth in mice and in human cells.
HERSHEY, Pa. — The first of a new class of medication that delivers a combination of drugs by nanoparticle may keep melanoma from becoming resistant to treatment, according to Penn State College of Medicine researchers.
Zinc levels in breast milk may be able to serve as an indicator of breast function during lactation, according to Penn State health researchers.
Seven Penn State faculty members have been named Fellows of the American Association for the Advancement of Science, the organization announced November 23, 2015.
This year's Samuel F. Hinkle Outstanding Young Investigator Award was presented to Willard M. Freeman, assistant professor in the Department of Pharmacology in the Penn State College of Medicine. Freeman earned his doctorate in pharmacology from Wake Forest University School of Medicine and joined the College of Medicine faculty in 2005. He serves as director of the Functional Genomics Core facility. Freeman was chosen from a list of accomplished researchers for his work in genomics and behavioral neurobiology to receive this award.
